Authors:
Miravitlles, M
Ros, F
Cobos, A
Kubin, R
Tillotson, G
Citation: M. Miravitlles et al., The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis:A spanish physician and patient experience, INT J CL PR, 55(7), 2001, pp. 437-441
Citation: F. Ros et R. Kunze, Regulation of activator/dissociation transposition by replication and DNA methylation, GENETICS, 157(4), 2001, pp. 1723-1733
Authors:
Ros, F
Garcia, R
Gallego, P
Sanchez-Caballero, A
Rivera-Fillat, MP
Grau-Oliete, MR
Citation: F. Ros et al., Synthesis of a series of 3-cyanopropionamides and 4-imino-gamma-butyrolactams and evaluation of their function as modulators of multidrug resistance, ARCH PHARM, 333(10), 2000, pp. 329-336
Authors:
Audouze, K
Ros, F
Pintore, M
Chretien, JR
Citation: K. Audouze et al., Prediction of odours of aliphatic alcohols and carbonylated compounds using fuzzy partition and self organising maps (SOM), ANALUSIS, 28(7), 2000, pp. 625-632
Citation: F. Ros, Formation of an imidosuccinimide by cyclisation of a sterically hindered beta-cyanoester with the lithium salt of a primary amine, J CHEM R-S, (3), 2000, pp. 124-125
Authors:
Torres, A
Bauer, TT
Leon-Gil, C
Castillo, F
Alvarez-Lerma, F
Martinez-Pellus, A
Leal-Noval, SR
Nadal, P
Palomar, M
Blanquer, J
Ros, F
Citation: A. Torres et al., Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin, THORAX, 55(12), 2000, pp. 1033-1039
Citation: F. Ros et Mt. Molina, Organic branched-chain compounds, 4 - A new racemic conglomerate and its characterization by the melting paint diagram - Formation of the metastable racemic compound, EUR J ORG C, (11), 1999, pp. 3179-3183